Joseph F Arboleda-Velasquez

Title: Joseph F. Arboleda-Velasquez: Innovator in Ocular Drug Delivery

Introduction

Joseph F. Arboleda-Velasquez is a prominent inventor based in Newton, MA (US). He has made significant contributions to the field of ocular drug delivery, holding a total of seven patents. His innovative work focuses on developing advanced formulations that enhance the treatment of ocular conditions.

Latest Patents

One of his latest patents is titled "Nano-emulsion of CBFβ-RUNX1 inhibitor for ocular drug delivery." This invention provides ocular formulations featuring a nano-emulsion composition, which includes a CBFβ-RUNX1 inhibitor. The composition is characterized by particles that are less than 200 nanometers in length in at least one dimension. Another notable patent is for "Anti-ApoE antibodies and polynucleotides thereof." This patent outlines methods and compositions aimed at preventing or treating cognitive decline associated with dementia, mild cognitive impairment, and neurodegeneration. It utilizes antibodies, peptides, fusion proteins, or genome editing systems that modulate HSPG/heparin binding affinities of ApoE.

Career Highlights

Throughout his career, Joseph has worked with esteemed organizations such as The Schepens Eye Research Institute, Inc. and Massachusetts Eye and Ear Infirmary. His work in these institutions has allowed him to advance his research and contribute to significant developments in ocular health.

Collaborations

Joseph has collaborated with notable colleagues, including Leo A. Kim and Patricia A. D'Amore. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Joseph F. Arboleda-Velasquez is a distinguished inventor whose work in ocular drug delivery has the potential to transform treatment methodologies. His innovative patents and collaborations reflect his commitment to advancing medical science.